GP2 and Erythema: For patients receiving GP2 + GM-CSF, maximum local toxicities experienced during the primary vaccination series (PVS) were grade 1 (70%), grade 2 (28%), or grade 3 (1%). The most common toxicities included erythema, induration and pruritis; the grade 3 toxicity was induration.